10-year survival of a patient with metastatic prostate cancer: Case report and literature review

Main Article Content

Kristian Krpina *
Dean Markić
Dražen Rahelić
Juraj Ahel
Nino Rubinić
Josip Španjol
(*) Corresponding Author:
Kristian Krpina | kristiank@net.hr


Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages combined is 98.8%. Patients diagnosed with metastatic prostate cancer have median survival from 2 to 3 years. We describe a case of 64-year old man who clinically presented with inguinal lymphadenopathy. Because of elevated PSA levels biopsy of prostate was done and adenocarcinoma was diagnosed. Biopsy of inguinal lymph nodes confirmed the diagnosis of prostate cancer. Hormonal treatment was started and at the most recent follow-up, 10 years later, the patient is asymptomatic with no clinical signs of disseminated disease.

Downloads month by month


Download data is not yet available.

Article Details